New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals
- PMID: 18988735
- PMCID: PMC2582310
- DOI: 10.1073/pnas.0808768105
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals
Abstract
Neuronal pigments of melanic type were identified in the putamen, cortex, cerebellum, and other major regions of human brain. These pigments consist of granules 30 nm in size, contained in organelles together with lipid droplets, and they accumulate in aging, reaching concentrations as high as 1.5-2.6 microg/mg tissue in major brain regions. These pigments, which we term neuromelanins, contain melanic, lipid, and peptide components. The melanic component is aromatic in structure, contains a stable free radical, and is synthesized from the precursor molecule cysteinyl-3,4-dihydroxyphenylalanine. This contrasts with neuromelanin of the substantia nigra, where the melanic precursor is cysteinyl-dopamine. These neuronal pigments have some structural similarities to the melanin found in skin. The precursors of lipid components of the neuromelanins are the polyunsaturated lipids present in the surrounding organelles. The synthesis of neuromelanins in the various regions of the human brain is an important protective process because the melanic component is generated through the removal of reactive/toxic quinones that would otherwise cause neurotoxicity. Furthermore, the resulting melanic component serves an additional protective role through its ability to chelate and accumulate metals, including environmentally toxic metals such as mercury and lead.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role.IUBMB Life. 2023 Jan;75(1):55-65. doi: 10.1002/iub.2654. Epub 2022 Jun 11. IUBMB Life. 2023. PMID: 35689524 Free PMC article.
-
Neuromelanins isolated from different regions of the human brain exhibit a common surface photoionization threshold.Photochem Photobiol. 2009 Jan-Feb;85(1):387-90. doi: 10.1111/j.1751-1097.2008.00476.x. Epub 2008 Nov 19. Photochem Photobiol. 2009. PMID: 19067944
-
Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure.PLoS One. 2012;7(11):e48490. doi: 10.1371/journal.pone.0048490. Epub 2012 Nov 5. PLoS One. 2012. PMID: 23139786 Free PMC article.
-
The comparative biology of neuromelanin and lipofuscin in the human brain.Cell Mol Life Sci. 2008 Jun;65(11):1669-82. doi: 10.1007/s00018-008-7581-9. Cell Mol Life Sci. 2008. PMID: 18278576 Review.
-
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.Prog Neurobiol. 2005 Feb;75(2):109-24. doi: 10.1016/j.pneurobio.2005.02.001. Prog Neurobiol. 2005. PMID: 15784302 Review.
Cited by
-
Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.Int J Mol Sci. 2024 Feb 7;25(4):2009. doi: 10.3390/ijms25042009. Int J Mol Sci. 2024. PMID: 38396687 Free PMC article. Review.
-
Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.J Neural Transm (Vienna). 2024 Mar;131(3):213-228. doi: 10.1007/s00702-023-02718-2. Epub 2024 Jan 18. J Neural Transm (Vienna). 2024. PMID: 38238531
-
Comparison of automated and manual quantification methods for neuromelanin-sensitive MRI in Parkinson's disease.Hum Brain Mapp. 2024 Jan;45(1):e26544. doi: 10.1002/hbm.26544. Epub 2023 Dec 2. Hum Brain Mapp. 2024. PMID: 38041476 Free PMC article.
-
Unravelling the Parkinson's puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies.Exp Brain Res. 2024 Jan;242(1):1-23. doi: 10.1007/s00221-023-06735-1. Epub 2023 Nov 28. Exp Brain Res. 2024. PMID: 38015243 Review.
-
Melanin: a unifying theory of disease as exemplified by Parkinson's, Alzheimer's, and Lewy body dementia.Front Immunol. 2023 Sep 29;14:1228530. doi: 10.3389/fimmu.2023.1228530. eCollection 2023. Front Immunol. 2023. PMID: 37841274 Free PMC article.
References
-
- Zucca FA, et al. The neuromelanin of human substantia nigra: Physiological and pathogenic aspects. Pigment Cell Res. 2004;17:610–617. - PubMed
-
- Kastner A, et al. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem. 1992;59:1080–1089. - PubMed
-
- Zecca L, et al. The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett. 2002;510:216–220. - PubMed
-
- Reyes MG, Faraldi F, Rydman R, Wang CC. Decreased nigral neuromelanin in Alzheimer's disease. Neuro Res. 2003;25:179–182. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
